Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
In the multiple ascending dose study, participants receiving the highest dose level of 48 mg achieved a striking mean body-weight reduction of 9.1% by Day 54, with weight loss trends showing no signs of plateauing
Discontinue use if irritation occurs
Without high-protein intake and resistance training, participants lost more muscle and less fat, as youd expect
Wegovy contains semaglutide and targets the GLP-1 hormone, while Mounjaro contains tirzepatide and targets both GLP-1 and GIP
US$ 24.19
US$ 29.40
US$ 23.07
US$ 28.32
US$ 28.33
US$ 27.75
